chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Rash on my body; blisters on my fingers in my feet; Fever; Chills; Fatigue; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 27 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 02Dec2021 (Lot number: 320308) at the age of 27 years as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications. The following information was reported: PYREXIA (non-serious) with onset 03Dec2021, outcome "recovered" (Dec2021), described as "Fever"; CHILLS (non-serious) with onset Dec2021, outcome "unknown", described as "Chills"; FATIGUE (non-serious) with onset Dec2021, outcome "unknown", described as "Fatigue"; RASH (non-serious) with onset 06Dec2021, outcome "unknown", described as "Rash on my body"; BLISTER (non-serious) with onset 06Dec2021, outcome "unknown", described as "blisters on my fingers in my feet". Therapeutic measures were taken as a result of pyrexia, chills.  Additional information: Reason for no lot number: of Covid 19 Vaccine: Other: LOT#: Consumer stated, "LOT# is 320308, I can't tell if that's a D or 0. No, its 320308 and then the Last symbol is either a D or 0. I think it's 0 at the end and not a D or 0. No, its 320308 and then the Last symbol is either a D or 0 (Not clarified). Patient was stated, "I was just calling to, I felt like I should tell you about my, sort of my reactions I had to COVID Vaccine." Consumer stated, "Well I had a fever, chills which I know it's one of the common one and fatigue. Now I have like a rash on my body and I have like a, just little like blister on my fingers in my feet." Patient was stated, "I had it on last Thursday, so that was on 02Dec2021(Confirmed as 02Dec2021)." Patient was stated, "I took a lot of Advil, I don't have a fever anymore, my fever started 24 hour after the vaccine (Further clarification unknown) and my 'fit' probably another, like there is fever and chills were on and off for about 36 hours I took an Advil and Tylenol (Further clarification unknown hence not captured) during that time. I now today, I started having the blisters and the rash." Dosage of Advil and Tylenol: Consumer stated, "I took probably 200 milligrams of the Advil every 8 hours and I took Tylenol, I took 2 capsules every 8 hours also. I am not sure the capsule were the Tylenol." Other Medical Condition and Medications: Consumer stated, "I am just taking birth control (Further not clarified hence not captured)." Patient was stated Anatomical site "My Left Shoulder."  Follow-up attempts are completed. No further information is expected.
3-4 minutes after receiving injection, began experiencing accelerated heart rate, sudden rush of heat throughout the body, weakness, feeling dizzy and faint. It went away after 1-2 minutes, but the same thing happened 15 minutes later, 60 min later, and 12 hours later.
pt recvd vax; high pitched cry for 1 hr; swelling at site of inject; apap given; DPH ordered by physician;
This spontaneous report as received from a pharmacist refers to unknown number of patients. On unknown dates the patients were vaccinated with ZOSTAVAX (dose, route and lot # not reported). The pharmacist reported that there might have been other patients that experienced injection site reactions following vaccination with ZOSTAVAX, but the pharmacist could not provide specific details of other injection site reactions with ZOSTAVAX at the time of the call. The outcome of injection site reactions is unknown. This is one of several reports received from the same source. Attempts are being made to obtain additional identifying information to distinguish the individual patients mentioned in this report. Additional information will be provided if available.
Tested positive for Covid-19 on 12/1/2021, six months after becoming fully vaccinated.
4 hr after vax, pt became cyanotic/ apneic. mother provided rescue breathing. pt responded about 1 min later. pt was admitted to hosp EEG, EKG, Blood
Information has been received from a health professional concerning an 83 year old female with hypertension, high cholesterol and a shellfish allergy who on Dec 27 2005 was vaccinated IM in the left arm with a second 0.5 ml dose of Pneumococcal 23v polysaccharide vaccine (lot 651329/1047P). Concomitant therapy included lisinopril (Zestril), warfarin sodium (Coumadin), potassium chloride (K Dur), furosemide (Lasix Furosemide), metoprolol succinate (Toprol XL Tablets), atorvastatin calcium (Lipitor), sertraline HCL (Zoloft), isosorbide mononitrate (Imdur), alprazolam (Xanax) and esomepraxole magnesium (Nexium). On Dec 29 2005 the patient called her physician to report that her arm was red, warm to touch and swollen at the injection site. She reported that it started on Dec 27 2005 after vaccination and she had been icing it. She was seen by the physician on Dec 29 2005 and he prescribed diphenhydramine and hydrochloride (Benadryl) and told her to continue icing the site. At the time of the report, the patient was recovering. there was no quality complaint involved. The patients events were considered to be other important medical events (OMIC). Additional information has been requested.
A headache that began the evening of 2/10 and lasted for 72 hours. Tylenol every 4-6 hours. Labored breathing and heavy chest feeling - began during the night of 2/10 and lasted for two days. Rested and used additional breathing treatment by nebulizer for two days. I also had great deal of fatigue, body aches, joint pain which began the following morning (2/11) and lasted about 24-36 hours. Tylenol helped. A general flu like feeling of blah.
02/12/2021- 9 PM -Left arm felt great pain at injection site,   Midnight- great pain again, chills, fever, no balance-dizziness, walking into walls, dresser.   02/13/2021-Exhausted, sleeping all day, cold-wrapped in blankets, headaches 02/14/2021- finally sitting up, starting to move around 02/15/2021- starting to recover to normalcy
Hospitalization for a fall and COVID-19 symptoms on dates 8/3/2022-8/16/2022.  Treated with dexamethasone,  vitamin C 1,000 mg PO daily, vitamin D 25 mcg PO daily, zinc 50 mg PO daily.?
Information has been received from a Nurse Practitioner concerning a 19 year old female with a history of abnormal Papanicolaou smear who on 14-DEC-2006 was vaccinated IM with the first dose of Gardasil.  Concomitant therapy included hormonal contraceptives (unspecified).  On 14-DEC-2006 the patient experienced fever.  In April 2007, the patient experienced fever, nausea and chills after receiving the second dose of Gardasil.  Subsequently, the patient recovered from all of her experiences.  Medical attention was sought.  Additional information has been requested. Initial and follow up information has been received from a nurse practitioner concerning a 19 year old female student with no known drug allergies, and a history of an abnormal papanicolacu smear, who on 14-DEC-2006 was vaccinated IM in the deltoid, with the first dose of GARDASIL (invalid lot #). The patient recalled she possibly had a "cold" at the time of vaccination. On 14-DEC-2006, following the vaccination, she developed a fever, and had chills and nausea. She recovered after 3 days. In April 2007, the patient was vaccinated at a school, with a second dose of GARDASIL (lot # not provided), and gain developed a fever, chills and nausea. The patient recovered this time after 7 days. Treatment was not specified. Additional information is not expected.
Starting on the day after the vaccine had body aches and his "back went out."  Has chronic back problems.   Also felt short of breath and felt like having some throat swelling.  Did not present for medical care during the time.  Slowly got better over the next several days.
shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of an unknown age. The patient's concurrent conditions, medical history and concomitant medications were not reported.  On or about 28-MAR-2014, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (dose, dose #, lot #, expiration date and route of administration were not provided) for the long-term prevention of shingles and/or zoster-related conditions by a pharmacist in a pharmacy. Subsequent to the patient's inoculation, the patient was treated by a healthcare provider for shingles. As a direct and proximate result of patient's use of zoster vaccine live (ZOSTAVAX) vaccine, patient has and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future.  The reporter considered the event to be related to zoster vaccine live (ZOSTAVAX).
Patient felt a sensation from her arm to her neck and started to feel hot, increased heart rate, and overall "weird"
On 7/15/98 pt recv vax; on 7/16/98 pt exp swelling of left thigh, also hives.
Severe itching and non-localized rash and hives, ranging in locale from the top of the head to the neck, chest, waist, groin, legs and feet.  They would often manifest in the form of "slashes" (as if scratched deeply) and often quite "geometric" in nature (imagine pulling tape off the body and leaving a 6" long and 1/4" wide red mark).  It has been CRUCIAL to have a STRONG discipline to not scratch because during an event any contact with the site(s), including via clothes, would greatly compound effect.  The presentation of symptoms was predictably FAR worse after a shower, particularly late at night.  Nighttime generally also seems to correlate with more events.  The locale of any particular rash/itch would last 30-60 minutes.  Those on the head would almost become oddly painful.   Severity was quite consistent for the first 2 weeks, then SLIGHTLY less the next 2 weeks, with a noticeable improvement in week 5.  I'm 99% certain that the Moderna Booster received on 12/21 was the ONLY cause for this.  I've NEVER been allergic to anything, and I had NO changes in behavior or diet or clothes or anything in my lifestyle in the 2 weeks preceding onset (12/29).  Topical creams (e.g., Hyrdocortisone) would SEEMS to help briefly, but not much.  A round of oral steroids (Prednisone, prescribed by an Urgent Care facility) taken Jan 2-8 did nothing at all to help.   Now, 6 weeks later, I feel 90% better, still with some random events (again, mostly at night).
Chest pain left side of chest; Dose Number: 1 Moderna /Dose Number: 2 Moderna/ Dose Number: 3 Pfizer; Dose Number: 1 Moderna /Dose Number: 2 Moderna/ Dose Number: 3 Pfizer; Dose Number: 1 Moderna /Dose Number: 2 Moderna/ Dose Number: 3 Pfizer; vaccine received same date: Moderna; This is a spontaneous report from a contactable consumer (patient). A 73-year-old male patient received the third dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: FH8020), in arm left on 25Oct2021 14:15 (at the age of 73-years-old) at dose 3 (booster), single for COVID-19 immunisation; COVID-19 vaccine MRNA (MRNA 1273) (MODERNA COVID-19 VACCINE; lot number: 012M20A) in arm left on 25Oct2021 at dose 3, single (reported as Dose Number: 1) for COVID-19 immunisation. Medical history included high blood pressure, cholesterol, prostate. The patient had not known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included unspecified medications received within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received second dose of MODERNA vaccine (lot number: 024M20A) in arm left on 03Mar2021 11:00 (at the age of 73-years-old) and first dose of MODERNA vaccine (lot number: 012m20A) in arm left on 27Jan2021 07:45 (at the age of 73-years-old), both for COVID-19 immunisation. The patient experienced chest pain left side of chest on 26Oct2021 07:00 AM. The event was reported as serious due to hospitalization for 1 day. The event resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care visit. The patient underwent lab tests and procedures, which included nasal swab on 25Oct2021 with unknown results; since the vaccination, the patient had been tested for COVID-19; in Oct2021 complete blood count (CBC) with auto differential, creatine phosphokinase (CK) total and CKMB, comprehensive metabolic panel (CMP), all with unknown results. An unspecified treatment was received for the event. The patient had not recovered from chest pain left side of chest, the outcome of the other event was unknown.
Fatigue; Pain at location of vaccine injection when pressing and lifting arm; This is a spontaneous report from a contactable Other Health Professional reported for herself. A 23-year-old female patient received 1st dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: EL3247), via an unspecified route of administration on 19Jan2021 at 14:00 at single dose on left arm for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. Patient was not diagnosed with COVID-19 prior to vaccination. Patient had not been tested for COVID-19 since the vaccination. Patient was not pregnant at the time of vaccination. The patient experienced pain at location of vaccine injection when pressing and lifting arm on 19Jan2021 15:00 with outcome of recovering. Fatigue and trouble getting out of bed the morning after the shot on 20Jan2021 with outcome of recovering. This case was reported as non-serious.
Expired Vaccine Administered (First Dose); This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired Vaccine Administered (First Dose)) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired Vaccine Administered (First Dose)). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired Vaccine Administered (First Dose)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: Additional crosslink reference IDs provided. Date of suspect product administration modified.
At clinic visit 4/1/04, mother told us of reaction after last shots given 1/29/04. 2 days later broke out over chest and back mainly and other areas large red welts, itching. Took to Emergency Dept. and next day to MD who thought it was reaction to MMR. Resolved one day later, Benadryl used.
Rash 10 days post vaccination seen in office for rash.  ATARAX Rx.
This spontaneous report was received from a healthcare worker refers to a patient of unknown age and gender. No concurrent condition or medical history was reported. On 16-JUL-2015, the patient was inadvertently vaccinated with 3rd dose of VARIVAX (Merck) (dose and route of administration not provided) (extra dose administered). No concomitant therapy was reported. No adverse effects were reported. The outcome of the event was unknown. No product quality issue was involved. Additional information has been requested.
After immunization on Sat 8/25 arm became red and by Tuesday it was red down to elbow (Rt arm). MD was visited and patient was given steroid injection & PO and Amox-clav 875 mg BID x 14 days. Symptoms are improving dramatically since then per patient.
I do not know the time of the incident. But he presented to ER with left sided weakness. He was found to have had a stroke and to have LV  noncompaction cardiomyopathy.
Family reported that pt developed redness, swelling & itching on (B) thighs after shots were given on 1/11/11. Pt seen in office 1/14/11. Noted to have 3-4cm raised red patch on (R) anterior thigh & 1 1/2 cm area on (L) anterior thigh. Prescribed Triamcinolone cream for itching. Pt to only get one shot in each limb at a time in the future.
She had to take to the Hospital because she is losing the blood, they told this is internal bleeding, so they gave her the blood transfusion but still losing the blood; This is a spontaneous report from a contactable consumer. This consumer reported for a female patient (Mother-in-law) of an unspecified age received second dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration, on an unspecified date, as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration, on an unspecified date, as a single dose for COVID-19 immunization. Reporter stated, "Why I am calling is that I have few questions about the side effects for the Pfizer Covid-19 vaccine vaccination. It was for my mother-in-law (consumer) after the second dosage vaccination, after one month. On an unspecified date, she had to take to the hospital, and she was losing the blood. I was just asking you was it normal after one month of the second dosage. She was losing the blood, they told this is internal bleeding but she didn't have any internal bleeding, so they gave her the blood transfusion but she was still losing the blood." The patient was hospitalized on an unspecified date. Reporter stated, "I will ask for my mother-in-law if she get more information, I would call because I want to get more information like was it from the vaccination if she gets advice from the Doctor, if they know the procedure to help her." Outcome of the event was not recovered.  Information about Lot/ Batch number have been requested.
Information has been received from a nurse concerning an unspecified number of patients of unknown age and gender. No concurrent or historical conditions were reported. Since unknown dates from 06-OCT-2015, the patients were inadvertently administered with improperly stored doses of PEDVAXHIB (lot # L014426, expiration date 08-MAR-2018, lot # reported as L012383, expiration date 10-MAR-2018, strength, dose and route unknown). No adverse effect had been reported. This is one of several reports received from the same reporter. Additional information has been requested.
COPD was not well controlled and during that time last year when she got the Fluzone HD vaccine they were increasing her COPD medications; the patient experienced shortness of breath; slight pain, redness and a rash at sight of the injection; slight pain, redness and a rash at sight of the injection; slight pain, redness and a rash at sight of the injection; slight pain, redness and a rash at sight of the injection; Initial information regarding this unsolicited valid non-serious case via Agency (reference number: 00294722) received from a physician and transmitted to Sanofi 30-Sep-2020.  This case involved a 71 years old female patient for whom chronic obstructive pulmonary disease (COPD) was not well controlled and during that time last year when she got the INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] vaccine they were increasing her copd medications and the patient experienced shortness of breath (dyspnoea), slight pain, redness and a rash at sight of the injection (vaccination site rash and vaccination site inflammation associated with vaccination site inflammation pain and vaccination site erythema).  Relevant medical history, past medical treatment, vaccination details, concomitant medications and family history were not provided.  Concurrent condition included COPD.   On an unknown date in the last year (as reported), the patient received a 0.5 mL dose of suspect INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE (lot UJ236AA, expiry date not reported) via intramuscular route in the left deltoid for prophylactic vaccination. The patient was also administered with Pneumococcal vaccine.  On an unknown date, the patient developed non-serious shortness of breath (dyspnoea), slight pain, redness and a rash at sight of the injection (vaccination site rash and vaccination site inflammation associated with vaccination site inflammation pain and vaccination site erythema) unknown latency following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE.   This patient had pre-existing COPD. Her COPD was not well controlled and during that time last year, unknown latency, following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE COPD medications were increased (condition aggravated).  Relevant laboratory test was not reported.  Final diagnosis was slight pain, redness and a rash at sight of the injection, the patient experienced shortness of breath and copd was not well controlled and during that time last year when she got the fluzone hd vaccine they were increasing her copd medications.   It was not reported if the patient received a corrective treatment.  At the time of reporting, the outcome was unknown for the reported events.
COVID 19; COVID 19; vaccine brand other= Moderna; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 55-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 22Mar2021 at 10:00 as dose 1, single (Lot number: ER8730), in left arm, on 12Apr2021 at 10:30 as dose 2, single (Lot number: ER8729), in left arm, on 21Oct2021 at 09:30 as dose 3 (booster), single (Lot number: FE3592), in left arm and on 06May2022 at 09:15 as dose 4 (booster), single (Lot number: FK9893) at the age of 54 years, in left arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 23Sep2022 at 09:30 as dose 5 (booster), single (Lot number: A57144b), in left arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 23Sep2022 at 09:30, outcome "unknown", described as "vaccine brand other= Moderna"; VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Return of covid symptoms of congestion, headache and positive test. Therapeutic measures were taken as a result of vaccination failure, covid-19 (Paxlovid from 19Nov2022 to 23Nov2022).
nausea,diaphoresis,inc resp,then fainted;911 called,but recovered in about 45sec & was lost to f/u;no other details expected;
Patient presented to the ER with abdominal pain, diagnosed with acute on chronic pancreatitis on 9.22.21 at facility. During this admission, patient was also diagnosed with acute on chronic hypoxic respiratory failure related to Covid-19 pneumonia. Patient was managed with steroids, Lovenox, patient refused IV access therefore Remdesivir was not given. Patient was made DNR and she agreed to Hospice. Patient and family agreed to inpatient hospice. Patient passed away on 10.4.21.